Search results
Why Sorrento Therapeutics' Shares Tumbled 23.4% in September
Motley Fool· 2 years agoWhat happened Shares of Sorrento Therapeutics (NASDAQ: SRNE), a biotech company that specializes in...
Why Shares of Sorrento Therapeutics Are Up Today
Motley Fool· 1 year agoShares of Sorrento Therapeutics (NASDAQ: SRNE) were up 25.8% Tuesday afternoon, after being up as much as 51.6% earlier in the day. The biopharmaceutical...
Further weakness as Sorrento Therapeutics (NASDAQ:SRNE) drops 12% this week, taking one-year losses...
Simply Wall St. via Yahoo Finance· 2 years agoSorrento Therapeutics, Inc. (NASDAQ:SRNE) shareholders should be happy to see the share price up 22%...
Bankrupt Sorrento Therapeutics Secures Court Approval for $75M Financing
Benzinga via Yahoo Finance· 1 year agoSorrento Therapeutics Inc (NASDAQ: SRNE) announced that the U.S. Bankruptcy Court for the Southern...
What Kind Of Investors Own Most Of Sorrento Therapeutics, Inc. (NASDAQ:SRNE)?
Simply Wall St. via Yahoo Finance· 2 years agoThe big shareholder groups in Sorrento Therapeutics, Inc. (NASDAQ:SRNE) have power over the company....
Sorrento (SRNE) Up on Positive Result From Lung Cancer Study
Zacks via Yahoo Finance· 2 years agoSorrento Therapeutics SRNE moved up 6.21% in August, during market hours, after the drugmaker...
Why Sorrento Therapeutics Stock Is on the Rise Today
Motley Fool· 2 years agoWhat happened Shares of the diversified biopharma Sorrento Therapeutics (NASDAQ: SRNE) are racing higher today. Specifically, the drugmaker's shares are...
Health Check: How Prudently Does Sorrento Therapeutics (NASDAQ:SRNE) Use Debt?
Simply Wall St. via Yahoo Finance· 2 years agoThe external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about...
Is a Surprise Coming for Sorrento Therapeutics (SRNEQ) This Earnings Season?
Zacks via Yahoo Finance· 1 year agoSorrento Therapeutics (SRNEQ) is seeing favorable earnings estimate revision activity and has a...
Sorrento Therapeutics Stock Nosedives After Filing Bankruptcy Paperwork
Benzinga via Yahoo Finance· 1 year agoCOVID-19 drug and vaccine developer Sorrento Therapeutics Inc (NASDAQ: SRNE) is filing for...